Larvol Delta - Glenzocimab-for-REperfusion-in-the-Setting-of-Endovascular-Therapy-for-Brain-infarctioN-GREEN-Study

glenzocimab (ACT 017) - Acticor Biotech

http://clinicaltrials.gov/ct2/show/NCT05559398

Jul 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next